Most Recent
Glencore-owned Viterra has taken its 10-year fight with Cargill to the High Court after an appeals court upheld a judgment putting it on the hook for almost $300 million in damages for misleading representations in the sale of malt producer Joe White in 2013.
The proposed $1.5 billion merger of Australian Clinical Labs and Healius -- two of Australia’s largest pathology services providers -- is likely to substantially lessen competition, the ACCC has warned.
A court has issued an injunction forcing the discontinuance of a negligence suit against accounting firm Pitcher Partners by the former owner of Zap Fitness, a case found to be barred by the terms of a settlement.
Infant formula maker Care A2 Plus has lost a bid for a freezing order against the former chief financial officer of Sports Flick as it appeals a finding she had no involvement in a fellow executive’s "deceitful" scheme over a $5 million World Cup streaming deal.
The ACCC has launched a competition review of Viva Energy's proposed $1.15 billion acquisition of South Australia-based On The Run Group, and the service station giant has already offered a sweetener to get the merger over the line.
A judge has found that preliminary discovery does not extend to information about the likely recovery of a claim, rejecting an argument that the relevant rule allows prospective plaintiffs to test whether litigation will be “worthwhile".
The Australian Competition and Consumer Commission has expressed concerns that Transurban's plan to acquire a majority stake in fellow toll road operator Horizon Roads will hinder competition for future toll road projects.
A judge has criticised HWL Ebsworth’s discovery efforts and ordered the law firm to try again in the firm’s dispute with a former partner claiming the company cut him out of a proposed ASX float in 2020.
A self-managed superannuation fund has taken Slater & Gordon to court to block the the acquisition of its shares in the firm as part of the plaintiff firm's takeover by private equity firm Allegro Funds, saying the 55 cents per share price is not fair and reasonable.
The developer of healthcare directory app Whitecoat must pay health insurer and joint venture partner NIB $1.6 million for loans that were never repaid following the app’s sale to the Commonwealth Bank for $42.5 million in 2021.